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The Ironman South Africa (IMSA) is one of 28 
global Ironman triathlon races and combines 
the sports of open water swimming (3.8 km), 
cycling (180 km) and running (42.2 km). 
Triathletes are exposed to more challenging environmental 
conditions and physiological demands than athletes 
participating in most other individual sporting events. The long 
duration and extreme physical and mental demands of the 
sport place severe strain on participants. Triathletes may 
consequently present with a variety of medical problems 
during the competition, including exhaustion and dehydration, 
muscle cramping, hypothermia, heat stroke and 
musculoskeletal injuries.[1,2,3] 
In most triathlon events, the swimming segment is potentially 
the most dangerous due to complications such as, accidental 
drowning, hypothermia and cardiac arrest.[3,4] The risk of 
adverse medical events is influenced by environmental aspects 
such as, water and air temperature, presence of currents and 
accidental collisions between athletes.[1] The cycling segment 
also presents environmentally-driven medical concerns. 
Dehydration and trauma from falling are injuries most 
frequently reported. Ironman distance triathlon injuries and 
dropouts occur mostly during the cycling and running sections 
respectively, most likely due to the cumulative physical and 
mental stress of the previous two segments, but results vary.[1,2]  
There is a need for ongoing scrutiny of injury and illness 
profiles of ultra-distance athletes. Such data are useful for 
monitoring long-term changes in the frequency and 
circumstances of injuries, and assist greatly in the preparation 
of medical services.[5] 
The aim of this study was to determine medical history, injury 
and illness profiles of athletes who received medical attention 
during the 2014 IMSA event, and to investigate the time and 
place of presentation. 
 
Methods 
This was a retrospective, cross-sectional study. The study 
population consisted of all the competitors who participated in 
the 2014 IMSA event. All athletes who required medical 
attention (‘patients’) during the event at the main medical tent 
and all of the medical posts or mobile units along the route were 
included in this study. Spectators and staff who received 
medical treatment were excluded. 
The information used in this study was obtained from the 
standard documentation of medical encounters by personnel 
on duty at the event. Medical and demographical information 
of all athletes requiring medical attention was documented as 
standard procedure at all IMSA events. Clinical diagnoses were 
made and recorded by clinical staff on duty. Diagnoses were 
made by means of history, clinical examination, including 
blood pressure, heart rate, core temperature measurement, and 
special investigations as needed, including blood gases, 
glucose, urea and electrolyte measurement, urinalysis, 
spirometry and ECG. The completed documentation was 
obtained from the Race Medical Director (RMD) and the 
information captured on a data collection form. For the 
purposes of this analysis, where a final diagnosis could not be 
made with the available resources, the main presenting 
symptoms that were treated were reported. Demographic
Background: There is a need for ongoing scrutiny of injury 
and illness profiles of ultra-distance athletes. This study aimed 
to record the medical history, illness and injuries of athletes 
receiving medical attention during the 2014 Ironman South 
Africa (IMSA) triathlon, and to investigate the temporal 
presentation of medical encounters. 
Methods: This was a retrospective, cross-sectional study. All 
athletes who required medical attention at the main medical 
tent and all of the medical posts or mobile units along the 
route were included in this study A total of 2 331 athletes 
started the race. Data included age, gender, time and stage of 
the race when  medical attention was required, pre-race 
medical history and medication use, illness and injuries 
treated, special investigations performed, and weather 
conditions. 
Results: Overall, 179 athletes (7.7%) required medical 
attention. The incidence of medical encounters was 7.8%. A 
significantly higher percentage of younger participants 
encountered medical problems (P = 0.04). Most patient 
encounters (80.1%) occurred after the race. The median 
duration of treatment was 26 minutes. Medication was used 
by 35.1% of patients during the race. The most common 
medical encounters were exertion-related (71.2%), gastro-
intestinal (16.4%), dermatological (11.9%), musculoskeletal 
(9.6%) and cardiorespiratory conditions (2.4%). 
Conclusion: Medical encounters occurred more frequently in 
later stages of the race. Most medical conditions were exertion-
related. Potential higher risk may be associated with 
medication use, recent illness, and in younger participants. 
Temporal stacking of medical personnel, planning of 
resources according to expected conditions, preventative 
measures for high-risk behaviour, and on-going data 
collection with comparable methodology are recommended. 
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information for all athletes was also obtained. Weather 
conditions on race day were provided by the SA Weather 
Service. Because of incomplete retrospective data obtained 
from the race medical documentation in a small number of 
cases, patient numbers from which percentages were obtained 
vary slightly. The actual numbers used are reflected in the 
results.  
All medical staff at the 2014 IMSA event were briefed prior 
to the event on accurate documentation of all medical 
encounters. In order to prevent inter-observer bias, only one 
author captured the data obtained from the medical records 
on the data collection forms.  
Data were analysed by the Department of Biostatistics, 
Faculty of Health Sciences, University of the Free State (UFS), 
using SAS version 9.3. Descriptive statistics, namely, 
frequencies and percentages (categorical variables) and 
means, and standard deviations (SD) or percentiles 
(numerical variables) were calculated. Subgroups were 
compared using Fisher’s exact test or chi-squared tests, with 
level of statistical significance set at 0.05.  
The study was approved by the Ethics Committee of the 
Faculty of Health Sciences, UFS (ECUFS 119/2014). 
Permission was obtained from the RMD of the 2014 IMSA 
event.  
  
Results 
Demographic data 
A total of 2 331 athletes started the race of which 82.0% (n 
= 1 911) were male and 18.0% (n = 420) female. During the 
event, 179 athletes (7.7%) reported to the race medical areas 
for attention. This represents 76.8 medical events per 1 000 
race starters. There was no statistical difference between 
male and female athletes, with 7.4% (n = 141) of male 
athletes and 9.1% (n = 38) of female athletes requiring 
medical attention (P = 0.24). 
The mean age of the patients was 37.7 years (range 21-63 
years; SD 8.4 years). Younger athletes between the ages of 
18-24 years had the highest percentage requiring medical 
attention (14.7%), followed by athletes in the 25-29 year age 
group (12.8%) (Table 1). Less than 10% of athletes in all 
other age groups required medical attention (P = 0.04). 
 
Race information  
The average wind speed, temperature and humidity levels 
were calculated for each segment of the race. The 
measurements for the swim segment were 3 km/h, 17.3°C 
and 81.5%, for the cycling segment 6.1 km/h, 19.7°C and 
84.3%, and for the running segment 7.8 km/h, 20°C and 
82.3%, respectively.  
Information regarding the time slots during which the 
athletes presented is depicted in Fig. 1. The 2014 IMSA 
event started at 06:00 and concluded at 24:00, with total 
possible duration of 18 hours. The highest percentage of 
athletes (n = 33; 18.4%) presented between 19h00 and 
19h59. There was an increase in patient presentation from 
16:00 until approximately 23:00, during which time 88 
patients (49.2%) attended the medical facilities. The 
median duration of stay was 26 minutes per patient (range 
2-161 minutes).  
Table 2 shows the part of the race during which the athletes 
presented. Most patients (n = 129; 80.1%) presented after 
completing the race. The second highest number of 
presentations were during the cycling segmentation (n = 17; 
10.6%). 
 
Pre-race medical history and medication use 
The use of chronic medication was reported by 19.5% (n = 34) 
of patients. The most common chronic medications were 
asthma medications (5.2%) and anti-hypertensives (4.0%). Of 
the 179 patients, 36.2% (n = 63) reported using acute medication 
in the three days before the race. The most common reported 
medications were non-steroidal anti-inflammatory medication 
(NSAIDs) (n = 22; 12.1%) and analgesics (n = 10; 5.8%). In the 30 
days preceding the event, 27.8% (n = 48) of the patients reported 
suffering from an illness. Thirty-six (20.8%) patients reported 
an upper respiratory tract infection (URTI) and five (2.9%) 
reported gastroenteritis. 
 
Table 1. Biographical variable of age (years)  
 
Athletes requiring medical attention 
during the IMSA 2014 event 
 
Age categories 
Yes (n = 174) 
n (%) 
No (n = 2 157) 
n (%) 
Total (n = 2 331) 
n (%) 
18-24 5 (14.7) 29 (85.3) 34 (1.5) 
25-29 28 (12.8) 191 (87.1) 219 (9.4) 
30-34 36 (8.1) 410 (91.9) 446 (19.1) 
35-39 33 (7.5) 410 (92.6) 443 (19.0) 
40-44 38 (7.0) 503 (93.0) 541 (23.2) 
45-49 16 (4.9) 308 (95.1) 324 (13.9) 
50-54 12 (5.9) 191 (94.1) 203 (8.7) 
55-59 4 (4.6) 83 (95.4) 87 (3.7) 
60-64 2 (7.7) 24 (92.3) 26 (1.1) 
65+ 0 (0) 8 (100.0) 8 (0.3) 
n = total number of athletes, % = percentage of total athletes 
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Medication use during the IMSA 
More than a third of patients (35.1%, n = 61) reported using 
medication during the race (Table 3). The most common 
medications were NSAIDs (16.1%) and analgesics (14.4%). 
 
Diagnoses, symptoms and signs 
Medical complaints encountered by medical staff at the IMSA 
were categorised in clusters, as presented in Table 4. The most 
common group of conditions was exertion-related (n = 137;  
64.6% of diagnoses made): 34.0% cases of exercise-associated 
collapse (EAC)/hypotension (n = 72), 9.4% dehydration 
(n = 20), 5.2% exhaustion (n = 11), 5.2% hypothermia (n = 11) 
and 5.2% exercise-associated muscle cramps (EAMC) (n = 11). 
Six cases of hyponatraemia were diagnosed (2.8%). 
Hypoglycaemia (n = 5) accounted for 2.4% of cases and 
hyperthermia (n = 1) accounted for <1%. 
The second most prevalent cluster of diagnoses was related 
to the gastrointestinal system (n = 29; 13.7%). Sixteen cases of 
nausea with or without vomiting were recorded (7.6%), 
followed by epigastric pain and diarrhoea (n = 6; 2.8% each), 
and one case of heartburn (<1%). The dermatological cluster 
contributed 9.9% (n = 21), mostly skin abrasions (‘road rash’) 
(n = 10; 4.7%), followed by blisters (n = 7; 3.3%), two bee stings 
(<1%) and one case of erythema and sunburn (<1%) each. 
Seventeen musculoskeletal diagnoses were recorded (8.0%): 
10 (4.7%) overuse injuries (low back pain, Achilles tendon 
pain, peroneal tendon pain, cervical muscle spasm, 
patellofemoral pain, and iliotibial band friction syndrome), 
and seven (3.3%) acute traumatic injuries (muscle sprains, 
ankle sprains, and shoulder dislocation).  
Five (2.4%) cardiorespiratory diagnoses were recorded, all 
potentially serious. One diagnosis of pulmonary embolism, 
atrial fibrillation, asthma, bronchospasm and sore throat with 
coughing each, were made.  
Special investigations 
Blood glucose testing was performed in 85.8% (n = 152) of the 
patients, while blood gas and urea and electrolytes were tested 
in 29.9% of the patients, respectively (n = 53). 
Electrocardiograms (ECGs) were done in three (1.7%) patients. 
 
Discussion 
Despite the increasing popularity of Ironman distance 
triathlons, there is a lack of data on injury and illness profiles 
in these events.[5] IMSA and other events rely on historical 
data collected from previous events to plan the medical 
facilities and services for future events. This requires data on 
the predicted number, nature and severity of the 
casualties.[2,5] 
 
Incidence of medical encounters 
Of the 2 331 athletes competing, 7.7% required medical 
attention. This is lower than the 10.1% documented for the 2013 
IMSA event.[6] Injury and illness rates are recorded and 
reported with inconsistent methodology, making results 
difficult to compare. There are many external event-related 
variables which influence medical encounter data, including 
environmental factors, distances, age and the level of 
competence of competitors.[1,2,7] Similar studies noted a 
treatment presentation rate of between 2% and 37.7%.[2,5] 
Medical staff can therefore estimate to manage approximately 
30% of race starters during the course of the event, but can 
amend the estimates according to recent statistics and 
environmental variables on race day. 
 
Timing of medical encounters 
The majority of medical encounters (80.1%) occurred after the 
race, while nearly half occurred in the last eight hours. Similar 
trends have been recorded in other Ironman events, with peak 
times of medical encounters coinciding with that of finishing 
times.[2,5] A positive correlation between the time of arrival and 
treatment duration has been recorded previously, meaning 
patients arriving later are expected to require longer treatment 
times.[5] Little has been published on the numbers and 
qualifications of medical personnel at Ironman events. A 
medical support team comprising a medical director, one 
additional physician per 200 athletes, one nurse per 100 athletes 
and additional paramedical and ambulance staff are 
recommended for a standard triathlon.[3] The onsite medical 
team for the half- and Ironman distance triathlon with 1 923 
participants in rural Canada consisted of 120 members, of 
which key personnel were five physicians, 11 nurses and 36 
paramedics.[2] Rimmer and Coniglione[5] concluded that 
medical care at amateur triathlon events should be planned 
according to the temporal flow of injuries throughout the event, 
and that medical support be increased by 20% to three doctors, 
nine nurses and support staff per 100 participants in the latter 
stages of triathlons. In this study, the peak patient intake was 
33 patients per hour, and the average intake for the last eight 
hours was 20 patients per hour. The IMSA medical plan 
provides for a staffing schedule according to expected patient 
flow, allocating one doctor and two nurses per four patients. 
Provision is made for 37 beds of which three are intensive care 
Table 2. Stages of the race completed by the athletes 
requiring medical attention during the 2014 IMSA 
event (n = 161) 
Stage n (%) 
Swim 2 (1.2) 
Stopped at first transition 0 (0) 
Stopped during cycling 17 (10.6) 
Stopped at second transition 4 (2.5) 
Stopped during marathon 9 (5.6) 
Completed the race 129 (80.1) 
n = total number of athletes, % = percentage of total athletes 
 
 
 
Table 3. Medication used during the 2014 IMSA by athletes requiring 
medical attention (n = 61) 
Medication n (%) 
Non-steroidal anti-inflammatory (NSAIDs) 28 (16.1) 
Analgesics 25 (14.4) 
Anti-diarrheal medication  7 (4.0) 
Muscle relaxants 7 (4.0) 
Anti-nausea/vertigo/abdominal cramp tablets 4 (2.3) 
Crampease™ (Johannesburg, South Africa) 3 (1.7) 
Antacids 3 (1.7) 
Magnesium tablets 2 (1.2) 
Salt tablets 2 (1.2) 
n = total number of athletes, % = percentage of total athletes 
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and two are equipped for surgical cases.[8] Using this formula, 
the maximum bed occupation in the IMSA medical facility has 
never exceeded 30 (Dr. Konrad Von Hagen, IMSA Medical 
Director, personal communication). Mobile or secondary 
units should be available along the cycling, running and 
changeover areas, and dedicated staff and equipment should 
be readily available on or near the water for swift 
management of emergencies from the swim event. 
 
Environmental factors 
The degree of environmental stress is a health risk factor in 
ultra-endurance events.[2,3] One contributing factor to the 
relatively low incidence of medical encounters in this study is 
the mild weather conditions during the race. The average 
ambient temperature, wind strength and humidity on race 
day were well within the norms of the environmental 
recommendations for triathlons.[1,3] 
 
Gender 
At both the 2013 and 2014 IMSA events, male patients 
comprised 79% and female patients 21% of the total number of 
athletes treated.[6] No statistical difference between female and 
male medical encounter rates were found in this study (P = 
0.24). Similar results were recorded in the Two Oceans Ultra-
marathon between 2008 and 2011.[7] Other gender-related risk 
data are ambiguous.[2,9] Further studies are needed to identify 
possible gender-specific modifiable risk factors in ultra-
distance athletes.  
 
Age and experience 
Athletes between the ages of 18-24 years had a significantly 
higher incidence of medical encounters than older athletes.  
Table 4. Diagnoses, symptoms or signs of athletes requiring medical attention 
Diagnosis cluster Diagnosis n* % of 177 patients % of 212 diagnoses 
Metabolic/Exertion-related   126 (71.2) 137 (64.6) 
 
Exercise associated collapse 
(EAC)/hypotension 
72 40.7 34.0 
 Dehydration 20 11.3 9.4 
 Exhaustion 11 6.2 5.2 
 
Exercise-associated muscle cramps 
(EAMC) 
11 6.2 5.2 
 Hypothermia 11 6.2 5.2 
 Hyponatremia 6 3.4 2.8 
 Hypoglycaemia 5 2.8 2.4 
 Hyperthermia 1 0.6 0.5 
Gastrointestinal   29 (16.4) 29 (13.7) 
 Nausea 16 9.1 7.6 
 Epigastric pain 6 3.4 2.8 
 Diarrhoea 6 3.4 2.8 
 Heartburn 1 0.6 0.5 
Dermatological   21 (11.9) 21 (9.9) 
 Skin abrasions (‘road rash’) 10 5.6 4.7 
 Blisters 7 4.0 3.3 
 Bee sting 2 1.1 0.9 
 Erythema 1 0.6 0.5 
 Sunburn 1 0.6 0.5 
Musculoskeletal   17 (9.6) 17 (8.0) 
 Lower back pain 4 2.3 1.9 
 Muscle strains 3 1.7 1.4 
 Ankle sprains 3 1.7 1.4 
 Achilles tendon pain 2 1.1 0.9 
 Peroneal tendon pain 1 0.6 0.5 
 Cervical muscle spasm 1 0.6 0.5 
 Patellofemoral pain 1 0.6 0.5 
 Shoulder dislocation 1 0.6 0.5 
 Iliotibial band friction syndrome 1 0.6 0.5 
Cardiorespiratory   5 (2.4) 5 (2.4) 
 Pulmonary embolism† 1 0.6 0.5 
 Arial fibrillation 1 0.6 0.5 
 Asthma 1 0.6 0.5 
 Bronchospasm 1 0.6 0.5 
 Sore throat and coughing 1 0.6 0.5 
Neurological   2 (1.1) 2 (0.9) 
 Concussion 2 1.1 0.9 
Unclassified   1 (0.6) 1 (0.5) 
 Urine discolouration 1 0.6 0.5 
n = total number of athletes, *A patient can have more than one diagnosis in a diagnosis cluster. 
†Diagnosis made on recent history of pulmonary embolism, chest pain, haemoptysis and ECG changes. 
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Even though younger age is suggestive of less experience, it  
does not necessarily reflect the association. However, these 
results correlate with the finding that less running experience 
is a risk factor for medical complications in ultra-marathon 
events.[9,10] This finding may be explained by self-selection of 
older, more experienced athletes with less career injuries, that 
older athletes possibly focus more on participation than 
winning, or address injuries earlier, before they escalate.[9] 
Analysis of possible preventable medical complications in less 
experienced athletes should be pursued further in order to 
introduce prevention strategies. Rule adaptations have been 
made, including dedicated novice starting waves to minimise 
psychological stress and physical risk at the start of these 
events.[1] 
 
Pre-race medical history and medication use 
Chronic medication use was reported by 19.5% of patients, 
and 27.8% suffered an illness in the 30 days before the 
competition. Pre-existing acute and chronic medical 
conditions may pose an increased risk for medical 
complications during endurance exercise. In this retrospective 
study, it is unknown if there is a difference in the prevalence 
of pre-race acute or chronic medical conditions between 
athletes who did not need medical attention and those who 
did. Therefore no conclusions can be drawn.  
Use of acute medication in the three days before the 
competition was reported by 36.2% of patients, and during the 
race by 35.1%. The prevalence of medication use among all 
participants is not known and relative risk cannot be 
calculated. However, the most commonly used medication in 
the three days preceding the race (12.1%) and during the race 
(16.1%) was NSAIDs. These figures are much lower than the 
30.0% of athletes using NSAIDs during the 2004 New Zealand 
Ironman.[11] In the 2008 Brazil Ironman, 59.9% of a cohort of 
participants reported using NSAIDs in the previous three 
months; of these, 25.5%, 17.9% and 47.4% took NSAIDs the 
day before, immediately before and during the race, 
respectively.[12] Underreporting may have occurred in this 
study because of the athletes’ apprehension to disclose risky 
behaviour. A high rate of non-prescribed NSAID use and 
limited awareness of the risks thereof have been reported in 
Ironman athletes.[12] 
 
Medical conditions treated during the 2014 IMSA 
The majority of patients (71.2%) treated during the 2014 IMSA 
suffered from exertion-related conditions which included 
EAC, dehydration and exhaustion. In the 2010 Redman 
Triathlon, Oklahoma, USA, dehydration accounted for 50.7% 
of medical encounters, while dehydration and exhaustion 
contributed 72% of medical encounters in the 1999 Hawaii 
Ironman event.[5] The incidence of EAMC (5.2%) was much 
lower than the 36.1% in the 2010 Redman Triathlon[5] and the 
11% in the Two Oceans Marathon from 2008-2011,[10] but 
similar to the 6% recorded in the Hawaii Ironman.[2] It seems 
that EAMC is more prevalent in shorter, faster events.[13,14] 
Hypothermia (5.2%) was more prevalent than hyperthermia. 
Low numbers of temperature regulatory dysfunction have 
been reported in ultra-distance events.[2,10] Nevertheless, 
proper management protocols for these potentially dangerous 
conditions should be in place.[3] Likewise, hyponatremia (2.8%) 
and hypoglycaemia (2.4%) were uncommon, but should be 
managed optimally. 
Gastrointestinal system complaints were the second most 
common group of conditions recorded. Non-specific diagnoses 
of nausea were made in 7.6% of patients. It can be challenging 
to make specific diagnoses of a general symptom, such as 
nausea, in a pre-hospital setting. Serious gastrointestinal 
conditions, such as gastrointestinal bleeding and ischaemia, 
have been recorded in ultra-endurance events.[1,2] Prompt 
referral should be done in persistent cases, or where systemic 
symptoms indicate more serious disease. 
The majority of dermatological (9.9%) and musculoskeletal 
(8.0%) conditions treated during the 2014 IMSA were minor, as 
reported previously.[9,10] Skin conditions consisted mostly of 
abrasions and blisters. Only one case of sunburn was reported. 
This may represent underreporting as athletes may have opted 
not to seek treatment for sunburn. Ultraviolet radiation was 
measured in three athletes in the 1999 Hawaii Ironman. Mean 
ultraviolet radiation exposure during the competition was 8.3 
times the minimal erythema doses, and greatly in excess of the 
International Radiation Protection Agency Guidelines, despite 
using sun protection factor 25+ sunscreen.[15] Copious amounts 
of sunscreen were made available to all participants during the 
IMSA 2014. 
The number of cardiorespiratory diagnoses was low (2.4%), 
but included potentially life-threatening conditions such as 
pulmonary emboli and atrial fibrillation. Such conditions 
should not be misdiagnosed for the much more common 
exertion-related diagnoses that can present in a similar way. 
Serious cardiorespiratory complications have been recorded in 
ultra-endurance events,[5,10] and medical facilities should be 
equipped to manage such emergencies. 
 
Special investigations 
The availability of basic special investigations and ECG were 
essential in the diagnosis and management of a high percentage 
of patients during IMSA 2014. These aids are potentially 
lifesaving and should be standard equipment available in ultra-
endurance events. 
 
Conclusion 
In this study, accurate reporting of all patient encounters 
during the 2014 IMSA was achieved. An accurate diagnostic 
profile, temporal presentation and consideration of factors 
that could potentially influence the profile of medical 
encounters allowed these authors to present an approach to 
planning of medical resources for future IMSA competitions. 
In accordance with previous studies, exertion-related 
medical conditions have been predominant in IMSA events. 
Potential preventative measures have been identified, 
including education on potentially harmful medication use 
during the race, recent illness, and prevention of medical 
complications in younger participants. 
Longitudinal prospective recording of medical encounters 
and associated factors, with standardised diagnostic criteria 
and terminology is recommended for ultra-endurance 
events to accumulate accurate evidence on which to plan 
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prevention and medical services. 
 
Limitations 
Limitations are, however, that data on all participants could 
not be obtained for comparison and risk calculation. 
Furthermore, the specific nomenclature of conditions and 
standardisations of diagnoses could not be done for a more 
accurate comparison with the literature, as diagnoses were 
obtained retrospectively from the clinical notes of medical staff 
on duty at the event. The relative lack of recent studies on the 
topic necessitated the use of older comparative literature. The 
severity of medical conditions was not recorded.  
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